Stay updated with breaking news from Harvard Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Harvard Bioscience (NASDAQ:HBIO – Free Report) in a research note published on Thursday morning. The brokerage issued a buy rating on the medical instruments supplier’s stock. Several other research analysts have also recently weighed in on the company. Benchmark boosted their price objective on Harvard Bioscience from $4.00 to […]
/PRNewswire/ -- The "Global Internet Of Things in Logistics Market by Software, Hardware, Organization Size, Application - Cumulative Impact of COVID-19,...
Acumen Research and Consulting recently published report titled “Electrophoresis Reagents Market 2023 - 2032”...
Q2 Revenues of $28.8 millionQ2 GAAP operating income $0.8 million, adjusted operating income $3.6 millionStrong H1 operating cash flow drove net debt reduction of $5.4 million HOLLISTON, Mass.,...